因塞特医疗 INCY 深 沪
等待开盘 02-05 09:30:00 美东时间
102.60
+1.680
+1.66%
华盛通- 最 高103.55
- 今 开102.61
- 成交量 186.87万股
- 最 低 101.44
- 昨 收 100.92
- 总市值 200.07亿
- 52周最高 112.29
- 市盈率 静 662.36
- 换手率 0.96%
- 52周最低 53.56
- 委 比 -38.89%
- 总股本 1.95亿
- 历史最高 153.15
- 量 比 1.15
- 振 幅 2.09%
- 历史最低 11.76
- 每 手 1
- 风险率 15.71%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Tafasitamab-Parsaclisib Trial Termination Tempers Incyte Outlook
Incyte ($INCY) announced an update on their ongoing clinical study. Tafasitamab...
今天 00:30
Barclays Maintains Overweight on Incyte, Raises Price Target to $116
Barclays analyst Etzer Darout maintains Incyte (NASDAQ:INCY) with a Overweight and raises the price target from $115 to $116.
02-04 22:24
Incyte Gets Positive Opinion From Medicinal Products For Human Use Of European Medicines Agency For Approval Of Zynyz
Incyte (NASDAQ:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz®
01-30 22:39
EMA Panel Recommends Approval of Incyte's Zynyz for Advanced Anal Cancer
EMA Panel Recommends Approval of Incyte's Zynyz for Advanced Anal Cancer Incyte Corporation announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination
01-30 22:29
Incyte Corporation published an update to their financial calendar
Incyte Corporation published an update to their financial calendar Incyte Corporation will release its fourth quarter and year-end 2025 financial results on February 10, 2026, at 7:00 a.m. ET. A conference call and webcast to discuss the results will be held on the same day at 8:00 a.m. ET. The live
01-28 01:15
美股大行评级 | 存储再获大行看好！花旗、瑞银和美银齐上调西部数据、希捷科技等公司目标价；PNC金融服务获6家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Soleno Therapeutics"买入"评级，目标价从110美元升至120美元；富国银行：维持Soleno Therapeutics"超配"评级，目标价从106美元升至114美元
01-21 11:42
IBM To Rally Around 8%? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a comple...
01-20 22:12
The 20 stocks hedge funds are most overweight
BofA screens for the 20 stocks that hedge funds like the most. These S&P 500 (SP500) (IVV) (VOO) stocks have the most net relative weight by hedge funds. Incyte Corporation (INCY) 32.26 Centene Corpor...
01-19 02:01
美股大行评级 | 高盛上调谷歌目标价从330美元升至375美元；5家大行集体上调Five Below目标价最高至255美元
今日重点评级关注：HC Wainwright & Co.：维持NioCorp Developments"买入"评级，目标价从9.5美元升至11.25美元；摩根士丹利：维持Chewy"超配"评级，目标价从48美元升至51美元
01-14 11:25
TD Cowen Maintains Buy on Incyte, Raises Price Target to $128
TD Cowen analyst Marc Frahm maintains Incyte (NASDAQ:INCY) with a Buy and raises the price target from $101 to $128.
01-14 03:06
